Description
Product Description
CD34, a transmembrane glycoprotein expressed on the surface of hematopoietic progenitor cells and small blood vessel endothelial cells, is regarded as a marker of hematopoietic stem cells (HSC) and hematopoietic progenitor cells [1]. CD34+ cells have been shown to possess colony-forming potential in short-term assays, maintain long-term colony-forming potential in in vitro cultures and allow the expression and differentiation of blood cells from different hematopoietic lineages in in vivo models [2]. The CD34+ Progenitor Cells contain two main cellular subpopulations, hematopoietic and endothelial progenitor cells. Therefore, CD34+ Progenitor Cells are suitable for a series of studies, e.g. directed differentiation into more committed types of blood cells and endothelial lineages.
iXCells Biotechnologies offers CD34+ Progenitor Cells from the peripheral blood of healthy donors. These cells are positively isolated using a direct immunomagnetic CD34 MicroBead labeling system. > 90% of the cells are CD34+ as showed by flow cytometric analysis of iXCells CD34+ Progenitor Cells.
Figure 1: The representative flow cytometry analysis result of Human Peripheral Blood CD34+ Cells.
Product Details
| Tissue | Human peripheral blood |
| Package Size | 0.2×106 cells/vial ;0.5×106cells/vial |
| Passage Number | P0 |
| Shipped | Cryopreserved |
| Storage | Liquid nitrogen |
| Growth Properties | Suspension |
| Media | Blood Cell Culture Medium (Cat# MD-0007) |
References
[1] Julie S. Nielsen, Kelly M. McNagny (2008). “Novel functions of the CD34 family.” Journal of Cell Science 121, 3683-3692.
[2] M Engelhardt, M Lu¨bbert and Y Guo. (2002). “CD34+ or CD34− : which is the more primitive?.” Leukemia, 16:1603-1608.
Reviews
There are no reviews yet.